Rafael Holdings reports Q2 fiscal 2025 results; merger with Cyclo Therapeutics set to close in Q3 pending approvals.
Unusual Whales The merger with Cyclo Therapeutics is expected to be completed in the third quarter, subject to approval from shareholders.